These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

590 related articles for article (PubMed ID: 825377)

  • 1. Derivation of specific antibody-producing tissue culture and tumor lines by cell fusion.
    Köhler G; Milstein C
    Eur J Immunol; 1976 Jul; 6(7):511-9. PubMed ID: 825377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fusion between immunoglobulin-secreting and nonsecreting myeloma cell lines.
    Köhler G; Howe SC; Milstein C
    Eur J Immunol; 1976 Apr; 6(4):292-5. PubMed ID: 825374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of antibody genes in tissue culture: structural mutants and hybrid cells.
    Milstein C; Adetugbo K; Cowan NJ; Kohler G; Secher DS
    Natl Cancer Inst Monogr; 1978 May; (48):321-30. PubMed ID: 107455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoglobulin biosynthesis by the MOPC 173 mouse myeloma tumor and a variant spleen clone.
    Baumal R; Scharff MD
    J Immunol; 1976 Jan; 116(1):65-74. PubMed ID: 812916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-peroxidase antibody-secreting hybrid lines. I. Identification, cloning and cell characterization.
    Zagury D; Phalente L; Bernard J; Hollande E; Buttin G
    Eur J Immunol; 1979 Jan; 9(1):1-6. PubMed ID: 374090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A monoclonal antiidiotypic antibody to MOPC 315 IgA inhibits the growth of MOPC 315 myeloma cells in vitro.
    Mahony J; Bose A; Cowdrey D; Nusair T; Lei M; Harris J; Marks A; Baumal R
    J Immunol; 1981 Jan; 126(1):113-7. PubMed ID: 7451962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A human myeloma cell line that does not express immunoglobulin but yields a high frequency of antibody-secreting hybridomas.
    Pickering JW; Gelder FB
    J Immunol; 1982 Jul; 129(1):406-12. PubMed ID: 6806365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of plasmacytomas on serum immunoglobulin levels of BALB/c mice.
    Fenton MR; Havas HF
    J Immunol; 1975 Feb; 114(2 pt 2):793-801. PubMed ID: 1089719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis but not secretion of J chain by variant mouse myeloma cells which lose alpha-chain-synthesizing ability.
    Mosmann T; Baumal R
    J Immunol; 1975 Oct; 115(4):955-62. PubMed ID: 809509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations affecting immunoglobulin light chain secretion by myeloma cells. I. Functional analysis by cell fusion.
    Mosmann TR; Baumal R; Williamson AR
    Eur J Immunol; 1979 Jul; 9(7):511-6. PubMed ID: 115698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatic cell hybrids of mouse myeloma cells and B lymphocytes from a patient with agammaglobulinemia: failure to secrete human immunoglobulin.
    Schwaber JF; Rosen FS
    J Immunol; 1979 May; 122(5):1849-54. PubMed ID: 109516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines.
    Kearney JF; Radbruch A; Liesegang B; Rajewsky K
    J Immunol; 1979 Oct; 123(4):1548-50. PubMed ID: 113458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatic variants in mouse myeloma and hybridoma cell lines.
    Yelton DE; Cook WD; Scharff MD
    Transplant Proc; 1980 Sep; 12(3):439-42. PubMed ID: 6784302
    [No Abstract]   [Full Text] [Related]  

  • 14. Glycosylation and secretion of an altered immunoglobulin heavy chain in mouse myeloma MOPC 315.
    Sonenshein GE; McCormack J
    J Immunol; 1982 Dec; 129(6):2559-63. PubMed ID: 6292292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of human monoclonal antibodies derived from lymphocytes of patients with cancer.
    Cote RJ; Morrissey DM; Oettgen HF; Old LJ
    Fed Proc; 1984 Jun; 43(9):2465-9. PubMed ID: 6327400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human bifunctional antibody generated by heterologous association of heavy and light chains.
    Tachibana H; Shirahata S; Murakami H
    Hum Antibodies Hybridomas; 1993 Apr; 4(2):42-6. PubMed ID: 8518364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological activity of a T hybrid line. I. Production of an H-2-related suppressor factor with specificity for sheep red blood cells.
    Taussig MJ; Corvalán JR; Binns RM; Roser B; Holliman A
    Eur J Immunol; 1979 Oct; 9(10):768-76. PubMed ID: 93051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the repertoire of anti-NP antibodies in C57BL/6 mice by cell fusion. I. Characterization of antibody families in the primary and hyperimmune response.
    Reth M; Hämmerling GJ; Rajewsky K
    Eur J Immunol; 1978 Jun; 8(6):393-400. PubMed ID: 97089
    [No Abstract]   [Full Text] [Related]  

  • 19. Arrangement of lambda light chain genes in mutant clones of the MOPC 315 mouse myeloma cells.
    Hozumi N; Wu G; Murialdo H; Baumal R; Mosmann T; Winberry L; Marks A
    J Immunol; 1982 Jul; 129(1):260-6. PubMed ID: 6806362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A myeloma hybrid producing antibody specific for an allotypic determinant on "IgD-like" molecules of the mouse.
    Pearson T; Galfrè G; Ziegler A; Milstein C
    Eur J Immunol; 1977 Oct; 7(10):684-90. PubMed ID: 73464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.